{
    "organizations": [],
    "uuid": "e5e51129c09418a33c951e200e47682b948f8ca6",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-horizon-pharma-announces-issuance/brief-horizon-pharma-announces-issuance-of-additional-notices-of-allowance-for-patent-applications-idUSFWN1SF0RH",
    "ord_in_thread": 0,
    "title": "BRIEF-Horizon Pharma Announces Issuance Of Additional Notices Of Allowance For Patent Applications",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 8 (Reuters) - Horizon Pharma PLC:\n* HORIZON PHARMA PLC - ANNOUNCES U.S. PATENT AND TRADEMARK OFFICE ISSUANCE OF ADDITIONAL NOTICES OF ALLOWANCE WITH CLAIMS COVERING RAVICTI ORAL LIQUID Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-08T20:35:00.000+03:00",
    "crawled": "2018-05-08T15:47:02.022+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "horizon",
        "pharma",
        "plc",
        "horizon",
        "pharma",
        "plc",
        "announces",
        "patent",
        "trademark",
        "office",
        "issuance",
        "additional",
        "notice",
        "allowance",
        "claim",
        "covering",
        "ravicti",
        "oral",
        "liquid",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}